← SEC 公告列表 | AVAH SEC 公告 | Aveanna Healthcare Holdings, Inc.（AVAH）

重大事件 即時報告 8-K 2026-05-15

Aveanna Healthcare 提交8-K，

於 SEC 網站開啟原文

AI 繁中摘要

📄 **8-K 申報摘要｜Aveanna Healthcare Holdings Inc.（股票代碼：AVAH）** **申報日期：2026年5月15日** Aveanna Healthcare Holdings Inc. 於本日提交一份 **8-K 表格**，主要根據 **Regulation FD（公平披露規則）** 向市場提供一份最新的投資者演示材料（Investor Presentation），該演示已於公司投資者關係網站 ir.aveanna.com 上載，並作為附件 99.1 一併提交。 --- ### 🔑 重點資訊 - 公司於 **2026年5月15日** 向投資者發佈了一份財務及業務演示報告，內容涵蓋近期營運亮點、財務狀況及未來策略方向。 - 該演示屬「提供」（furnished）而非「正式申報」（filed），因此不視為《交易法》第18條下的申報文件，亦不自動納入其他SEC申報中。 - Aveanna 同時提醒投資者，公司官方網站（ir.aveanna.com）及社交媒體渠道會作為重要資訊發放渠道，包括新聞稿、投資者演示及財務數據。建議投資者定期瀏覽「投資者」欄目，並可登記收取自動電郵通知，以掌握最新時間敏感資訊。 --- ### 📊 對投資者的潛在影響 - 雖然本次8-K並未披露具體業績數字或重大交易，但投資者演示通常會包含管理層對業務趨勢、增長動能及行業展望的看法，有助市場了解公司短期策略。 - 公司強調「在正式新聞稿或SEC申報前，可能先透過網站發布時間敏感資訊」，意味着投資者需主動關注官方網站及社交媒體，以免錯失重要訊息。 - 由於演示屬於自願性披露，投資者應結合後續季度財報（如10-Q）及年報（10-K）進行全面分析。 --- ### 💡 總結 是次8-K申報屬於例行性 **FD披露** 安排，核心目的是向市場公平傳達投資者演示材料，並提醒投資者關注公司官方渠道的動態。沒有即時影響股價的重大事件，但演示內容或提供業務轉型及成本優化的細節，值得細閱。
展開英文正文 
8-K
 
 
 
 false000183233200018323322026-05-152026-05-15

 

  
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 
 
 
 

 
 Date of Report (Date of earliest event reported): May 15, 2026

 

  
 

Aveanna Healthcare Holdings Inc.
(Exact name of Registrant as Specified in Its Charter)
 
 

 
 
 
 
 
 
 
 

 
 Delaware

 001-40362

 81-4717209

 

 
 (State or Other Jurisdiction
of Incorporation)

 (Commission File Number)

 (IRS Employer
Identification No.)

 

 
  

  

  

  

  

 

 
 400 Interstate North Parkway SE

  

 

 
 Atlanta, Georgia

  

 30339

 

 
 (Address of Principal Executive Offices)

  

 (Zip Code)

 

  

 
 
 
 

 
 Registrant’s Telephone Number, Including Area Code: 770 441-1580

 

  

 
 
 
 

 
  

 

 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: 
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:

 
 
 
 
 
 
 
 

 
 
Title of each class

  

 Trading
Symbol(s)

  

 
Name of each exchange on which registered

 

 
 Common Stock, par value $0.01 per share

  

 AVAH

  

 The Nasdaq Stock Market LLC

 

 Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). 
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 

 

 
 

 Item 7.01 Regulation FD Disclosure.
On May 15, 2026, Aveanna Healthcare Holdings Inc. (the "Company", "we", "us", or "our") made available a financial presentation to investors. A copy of the presentation is attached hereto as Exhibit 99.1 and incorporated by reference in this Item 7.01. A copy of the presentation is also available on our website at ir.aveanna.com.
 
Use of our Website and Social Media to Distribute Material Company Information
 
We use our website as a channel of distribution for important Company information. We routinely post on our website important information, including press releases, investor presentations and financial information, which may be accessed by clicking on the “Investors” section of www.aveanna.com. We also use our website to expedite public access to time-critical information regarding our Company in advance of or in lieu of distributing a press release or a filing with the SEC disclosing the same information. Therefore, investors should look to the “Investors” section of our website for important and time-critical information. Visitors to our website can also register to receive automatic e-mail and other notifications alerting them when certain new information is made available on our website. Information contained on, or accessible through, our website is not a part of and is not incorporated by reference in this Current Report on Form 8-K.
 
The information contained in this Item 7.01, including in Exhibit 99.1 attached hereto, is “furnished” and not “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference in another filing under the Exchange Act or the Securities Act, except to the extent such other filing specifically incorporates such information by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
 

 
 
 
 
 
 

 
 Exhibit Number

  

  
Description

 

 
 99.1

  

 Aveanna Investor Presentation - May 2026

 

 
 104

  

 Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

  

 

 
 

 SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
 
 
 
 
 

 
  

  

  

 AVEANNA HEALTHCARE HOLDINGS INC.

 

 
  

  

  

  

 

 
 Date:

 May 15, 2026

 By: 

 /s/ Matthew Buckhalter

 

 
  

  

  

 Matthew Buckhalter
Chief Financial Officer
(Principal Financial Officer)